Semaglutide can be transformational, especially for people like Maria who have struggled for years with traditional therapy
Compounded or research-grade combinations of cagrilintide and semaglutide require separate reconstitution and potentially separate injections, adding complexity
Mild to moderate nausea, constipation, fatigue, and appetite loss fall within expected adjustment symptoms and typically improve with time and lifestyle modifications
Had a 38% lower risk of major HF events after two years (composite of first urgent HF visit, HF hospitalization, oral diuretic intensification, and CV death)
Patients who may derive particular benefit include: People with type 2 diabetes and hypertension : This combination is extremely common, affecting a substantial proportion of people with type 2 diabetes